Helus Pharma Inc. logo

Helus Pharma Inc.

HELP | NASDAQ
Chart Builder DCF Calculator
$10.60
-$0.11 (-1.03%)
At close: Oct 30, 2026, 4:00 PM ET
$10.76
+$0.16 (+1.48%)
Pre-market: Nov 2, 2026, 5:54 AM ET
Fiscal Year
Period Ending
FY 2026
Mar 31, 2026
FY 2025
Mar 31, 2025
FY 2024
Mar 31, 2024
FY 2023
Mar 31, 2023
FY 2022
Mar 31, 2022
FY 2021
Mar 31, 2021
Net Income
-147.05M -113.14M -78.08M -47.49M -67.63M -32.22M
Depreciation & Amortization
119.23K 475K 424K 251K 168K 49K
Stock-Based Compensation
n/a 42.87M 13.89M 4.69M 18.03M 11.55M
Other Working Capital
-320.94K -8.38M -3.94M -489K 986K 729K
Other Non-Cash Items
15.76M -21.71M -111K -3.44M 4.01M 2.86M
Deferred Income Tax
n/a n/a n/a n/a n/a n/a
Change in Working Capital
-1.25M -9.79M -5.03M -1.44M 213K -1.27M
Operating Cash Flow
-132.42M -101.3M -68.91M -47.43M -45.21M -19.03M
Capital Expenditures
-1.36M -1.97M -710K -3.31M -520K -231K
Cash Acquisitions
9.94K n/a 7.63M n/a n/a -958K
Purchase of Investments
n/a n/a n/a n/a -250K n/a
Sales Maturities Of Investments
n/a n/a n/a n/a n/a n/a
Other Investing Acitivies
n/a n/a n/a -3.17M -415K -96K
Investing Cash Flow
-1.35M -1.97M 6.92M -3.31M -770K -1.19M
Debt Repayment
24.19M -290K -149K n/a n/a n/a
Common Stock Repurchased
n/a n/a n/a n/a n/a n/a
Dividend Paid
n/a n/a n/a n/a n/a n/a
Other Financial Acitivies
n/a n/a n/a n/a n/a 6.49M
Financial Cash Flow
196.97M 20.2M 254.51M 13.56M 35.78M 82.73M
Net Cash Flow
63.96M -73.97M 192.36M -37.01M -10.39M 62.48M
Free Cash Flow
-133.79M -103.27M -69.62M -50.74M -45.73M -19.26M
Adj. Free Cash Flow
-133.79M -146.14M -83.5M -55.43M -63.76M -30.81M
Maintenance CapEx
-119.23K -1.38M -710K -3.21M -520K n/a
Growth CapEx
-1.25M -588.24K n/a -97.22K n/a -231K
Owner Earnings
-132.54M -102.68M -69.62M -50.64M -45.73M -19.03M

© 2026 bestshares.com. All rights reserved.

All data is for informational purposes only. bestshares.com is not a broker, dealer, or registered investment adviser, and nothing on this site is a recommendation to buy or sell any security.